What are the drugs and doses for VTE prophylaxis in clinical and surgical inpatients?

VTE prophylaxis in clinical and surgical inpatients involves using LMWH, DOACs, UFH, and fondaparinux, with doses tailored to surgical context, patient renal function, and other factors. No direct comparative evidence suggests universally superior choices, emphasizing individualized regimen decisions.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-17
DOI
https://doi.org/10.5281/zenodo.24310615
Primary Topic
Venous Thromboembolism Diagnosis and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

What are the drugs and doses for VTE prophylaxis in clinical and surgical inpatients?

Tripdatabase
Zenodo (CERN European Organization for Nuclear Research)
Venous Thromboembolism Diagnosis and Management
article

What are the drugs and doses for VTE prophylaxis in clinical and surgical inpatients?

Tripdatabase
article en

Abstract

VTE prophylaxis in clinical and surgical inpatients involves using LMWH, DOACs, UFH, and fondaparinux, with doses tailored to surgical context, patient renal function, and other factors. No direct comparative evidence suggests universally superior choices, emphasizing individualized regimen decisions.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Venous Thromboembolism Diagnosis and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon